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Imaging Combines Molecular 
Information with Anatomy




















































MRI Imaging:  Concepts
• Proton spins resonate with RF pulse in high 
magnetic field gradients: Slice imaging
• High magnetic field high MRI signal 
(900 MHz is highest field 21 T MRI magnet at NHMFL)
(171 MHz is highest field 4 T MRI approved by FDA)
(64 – 128 MHz is routine 1.5 – 3 T MRI in hospitals)
• T1, T2, proton density weighting by scan parameters of TE, 
TR, TI etc.
• Quantitative Analysis: Interactive co-analysis by MRI and 





































Optimized Scan parameters: TR, TE, FOV, NEX, ETL, 
• 2D Slice imaging: MSME, DWI, EPI, 
• 3DVolume imaging: FLASH, RARE; Factors: ST, SNR
• Dynamic imaging: SENSE, GRAPPA
Registration: Edge-detection, Morphometry-matching
Segmentation: Classification of tissues
Boundary-based; Region-based: Thresholding,  Feature plot
• Masking to highlight subtle points 
• Manipulation and Analysis: Interactive
• Surface rendering: Surface Formation Contours, Patches, Surface Tracking; 
Rendering: Hidden-part removal, Shading
• Volume Rendering: Preprocessing Binary volumes, Gray Volumes
• Preprocessing: VOI selection
• Filtering 
• Interpolation






































































Quantitative MRS + MRI predict Hippocampal
Volumes and measure the Neurometabolites 
MRS
Sharma(2005) Medical Inform. 1(2) 55.
MRI




































PRESS: H-1 MRS of Hippocampus



































Quantitative MRSI: Slice Selection,
Metabolite Maps and CSI imaging
•Selective Single Voxel 
Spectroscopy(left)
•Single Plane Chemical 
Shift Imaging





































MRS metabolite peaks in Normal 
Volunteer



































Quantitative Proton Magnetic Resonance 
Spectroscopic Imaging(MRSI) Technique
• Data Acquisition:
-In-house developed MRSI sequence (AFFIRMATIVE)
-Prelocalization with stimulated sequence
-Volume-of-interest 90 x 90 x 15 mm3 with centrum semiovale
-Field-of-view 240 mm2
-32 x 32 phase encoding steps; TE/TR/NEX=30/1000/1;
-Bandwidth 1000 Hz; data points 256; voxel size 0.8 cc 
• Image Postprocessing
-Outer volume suppression for minimizing extramengial lipids
-Variable TR for reducing scan time
-Automatic analysis software (APSIP)
-Spectral analysis
-Metabolic map generation, Segmentation, Co-registration



































Outcome of Quantitative MRI-SI
• Calculation of number and volume of Gd-enhancing lesions 
• Calculation of number and volume of T2 lesions 
• Calculation of number and volume of T1 hypointense lesions 
• Calculation of brain atrophy, gray and white matter atrophy 
• Calculation of regional brain atrophy (26 regions) 
• Calculation of third ventricular width and bicaudate ratio 
• Calculation of lateral ventricular volume 
• Calculation of magnetization transfer ratio (MTR) (including WB-MTR, NABT-MTR, NAGM-MTR and 
NAWM-MTR) 
• Calculation of regional MTR (26 regions) 
• Calculation of diffusion tensor imaging (DTI) measures (ADC, FA, entropy) and tractography 
• MRI Spectroscopy analysis 
• MRI Iron measures analysis 
• FMRI analysis 
• PET-MRI combined analysis 
• Optic nerve analysis (including determination of lesions, calculation of optic nerve atropy, MTR, and DTI 
measures) 
• Spinal cord analysis (including determination of lesions, calculation of spinal cord atrophy, MTR, and DTI 
measures) 
• Development of MRI pulse and software programs, web-based programs and slide animations
•Transfer and storage of MRI scans from various MRI acquisition centers 




-Conversion of image format 
-Coregistration 



































MS: Non-Inflammatory GM 
Lipid Disorder
• Multiple Sclerosis(MS) shows lesions due to 
demyelinating White Matter disorder
• Occasional presence of GM lesions on MRI
• Multiple Sclerosis is non-inflammatory with 
lipid-rich Normal Appearing White Matter or 




































Can we measure MS load by 
MRI/MRS?
Hypothesis
Lipids accumulate and NAA lost initially 
followed by amino acid release at lesion 
sites.




































•MRI images at different level (top) 
•Different color-coded tissues(GM,WM,CSF, lesion 







































Feature maps of different regions in MS 





































PROMISCOL Trial: MS Lesions Showing Abnormal
Tissue and Metabolites in WM/GM and NAWM/GM





































PROMISCOL® Trial: Time dependent 










































Quantitative MRI + MRSI of 
Alzheimer’s Disease
AD: Amyloid plaques, hippocampal atrophy 
change due to dementia
Hypothesis
MRI combined with  MRSI characterize & 





































(supervised K-NN cluster method)
Sharma (2002) Adv. Segmentation Chapter 7,187



































MRSI: Metabolite* distribution  
and tissue content in AD
*Atrophy corrected metabolite concentrations of NAA, Cho, and Cr and 
NAA/Cr and NAA/Cho ratios from right and left hippocampus in AD 
patients and control subjects.  
@Tissue content  (in percent of  the MRSI voxel volume) and gray matter 
index (f) of the MRSI voxels positioned at right and left hippocampus, 
characterizing MRSI partial volume effects.
Metabolite         AD            Control      % Diff       Metabolite AD               Control       % Diff
ratio
NAA(mM)                                                                      NAA/Cr
Right                7.55 + 0.5   10.01+0.6       13.2                Right                1.08 +.06        1.39+.03          20.8                           
Left                   7.61 + 0.4    9.82 +0.9       22.6               Left                   0.96 +.04       1.31+.02           26.7 
Cho(mM)                                                                       NAA/Cho
Right                 2.02 + 0.7   2.08 + 0.2       2.9                 Right                3.74 +.07        4.81+.09           22.2               
Left                   2.04 + 0.4    1.89 + 0.5      7.4                 Left                   3.73 +.03          5.1+.06           26.9
Cr(mM)                                                                       @ Tissue content  (%)
Right                 7.02 + 0.6    7.75 + 0.5     9.4                 Right                    84 + 3            98+ 2             14.3                   
Left                   7.96 + 0.6     7.49 + 0.8    5.9                  Left                       87 + 3           96 + 3             0.93
Gray matter index (f)
Right                 0.45 + 0.03        0.55 + 0.05    18.2
Left                    0.62 + 0.02       0.62 + 0.04      n.s.



































AD: Where are sites of poor glycolysis?



































Anisotropy for Fiber Tracking:



































MRI+MRSI Predicts Better Tissue 
Composition and Volume in AD
AD              Control           % diff. 
HP-volume(mm3) 
Right                         1982 + 134    2884 +102           31.1     
Left                            1868 + 88      2943 + 86            36.5 
Ventricular CSF(%)       4.2 + 0.3        2.8 + 0.3          33.3
Sulcus CSF (%)            23.4 + 2         18.2 + 0.5           22.2
White Matter(%)          35.2 + 0.9       38.1 + 0.8           7.6
Cortical GM(%)           38.8 + 1.1        42.2 + 0.6           8.0
Subcortical GM(%)       1.2 + 0.08        1.4 + 0.03        n.s
TIV(cm3)                       1342 + 5          1402 + 52           n.s.
FDG-PET+MRI
Asymmetry Index > 3        12                     0                
NAA/(Cho+Cr)                  1.2                    5.4                          
AI > 12 % 7 1



































MRI + MRSI: Epilepsy
• Neocortical Epilepsy
• Mesial Lobe Epilepsy




































Combined (multislice MRI+ PRESS MRSI) 
in mLE
• Unilateral mTLE (ipsilateral side)
• PRESS volume pre-selection on 
hippocampus(TR/TE=1800/140 ms; 
voxel 9 x 9 x 15 mm3); circular K-space 
encoding of 24 points
• Multislice (TR/TE=1800/140 ms; voxel 
8 x 8 x 15 mm3); circular K-space 



































Hippocampus Volume Reduction and 





































MRSI: Metabolites in Pre-op vs 
post-op Epilepsy



































Neurochemicals by MRS lateralize 



































NAA/(Cr+Cho) in Control vs Epilepsy ipsi- and 
contra-lateral sides at different brain regions








































• Gray Matter and Normal Appearing 
Gray Matter and White Matter regions 
in MS are abnormal and measurable
• Neurochemicals in AD, Epilepsy 
suggest the utility of MRI and MRS 
to confirm
hippocampus volume heterogeneity 
and regional (tissue composition and 
neurochemical) differences due to 



































Outcome of MRI +MRSI
• Metabolites measure optimum lateralization
• Decreased NAA to hippocampus atrophy
• Bilateral abnormalities by asymmetry index
• Relationship of MRS peaks with post-op surgery 
seizure condition (bilateral abnormalities)
• Lateralization and discordance of lobes:
Atrophy; HV;T2; NAA; NAA/(Cho+Cr) 




































Maccaque Monkey Brain images 









































































 g-Amino butyric acid: 
C4H9NO2
• methylene groups form 
A2M2X2 system
 g and b protons are 
weakly coupled, A2X2










































The challenge of GABA detection
• GABA conc. in the healthy right 
occipital cortex: 1.0 mM
• Signal 40.000 times smaller













































GABA detection = 















































Voxel size = 27 cc, TA = 6’24 min



































MAGNETOM Trio: GABA Editing
 svs_se_edit 
In vivo spectral editing (MEGA, 2-shot)
 TE 68 ms
 voxelsize = 27 cc
 TA = 6’24min
 8-Channel Array Coil and offline signal combination 







































• GABA is inhibitory neurotransmitter
• GABA is predictive of seizure outcome








































































21 T MRI of Mice Brain
Aim: MRI imaging of mice brain anatomy
Outcome: Frontal(F), Parietal(P),Temporal(T), 









































First time 21 Tesla MRI processed 
images of Mice Brain Reveal Details 



































21 T MRI: Colchicine Injection in Mice 




































• Mouse brain hippocampus is MRI visible in 
different regions 




































21 Tesla MRI Microimaging
Possibility of imaging cells and 
measurement up to 20 micron 




































Micro-scale resolution by MRI
Aim: MRI of 50 μm, 90 μm, 500 μm polymer beads in tube with FeO-
Gadolinium
Outcome: MRI visualizes 50 μm beads(left) and ½ mm beads(rightmost)
Experiment: Polymer 50 μm beads(left) and 500 μm beads(right) were 
pushed in device at physiologic conditions & imaged by SE using T1 
and proton density weight




































First time Carbon Nanotube Transport Across 
The Skin by 21 Tesla MRI
Skin       CNT
•Carbon Nanotubes (CNT) as 
future drug delivery system
•CNT are 1.8 million times 
lighter than iron.
•CNT can penetrate anywhere 
across the membrane channels 




































• Microimaging provide high sensitivity and 
resolution upto micron level
• Microimaging can be useful in micro-
Anatomy, subcellular transport physiology
• Final Take-home Message:
Quantitative MRI/MRS with PET is future 
molecular imaging choice, while 
Quantitative Microimaging is future 






































































Sodium [Na]ex and [Na]i are MRI visible by 
IR pulse sequence at different null points
•Null points of [Na]ex and [Na]i are different
•Null point is inversion Time(TI) specific
•Distinct null points are tools for contrast









































































Simultaneous Imaging of a [F-18]-FDG Mouse Head 
with Two Coincident APD Based LSO Block-Detectors 
and a 7 Tesla Small Animal MRT System
• Step and shoot PET acquisition (12 angles, each 6 min) while MRT images were taken.
• Filtered Back Projection (2.5 mm Gaussian image filtering post reconstruction)
70/30 Bruker Biospec system. B-GA20 gradient set. Micro Imaging 







































– Surgery and RT: 
delineation of functionally 
significant brain sections 
and tumor mass
– Movement disorders:
Delineation of gray matter 
with receptor density
– Dementia: Structure 
volumetry and metabolism 
(FDG) or even Plaque 
Imaging (FDDNP)
– Stroke: improve MR 
perfusion by functional PET 











































Homogeneity Magnetic Field Material restriction




?? RF Field TX Signal interference
Signal interference RF Field RX Shielding








































































Functional MRI Measures the Blood 
Oxygen Stimulated Neuroactivation













































Ching J Chen, Bruce Locke, 




University of Texas Medical 
School, Houston
Ponnada A.Narayana               
Jerry Wolinsky
Thank You











































































































































• IMAPS: An International Multi-Center 
Assessment of Prostate Spectroscopy
• Prostate Spectroscopy using Array Coils
• Spectroscopy of the Spinal Cord
• Detection of GABA
• Fast CSI I: EPSI
• Fast CSI II: SSFP
• 31P Spectroscopy of the Heart: Improvements







































































Breast Cancer - Clinical 1H 
MRS Studies
• (ce)MRI provides high sensitivity for differential diagnosis
• Will Cho-detection by 1H MRS improve specificity?
– overall cancer types true positive detection rate: 74 %
– sensitivity low for non-infiltrating & high for infiltrating carcinoma
– axillary node metastasis: sens. = 82%, spec. = 100%, acc. = 90 %
– all results with respect to FNAB as gold standard



































svs_se_bB1 = svs_se + Spectral Suppression
• optimized spectrally selective pulses
• applied twice during TE; TEmin = 100 ms
• lipid and water suppression
• Acquisition using the 
Siemens Breast Coil



















































































































































• voxelsize = 6 cc, TA = 6 mins. 24 s



































Breast Cancer: Coherent Accumulation

















































































































































































































































MAGNETOM  Tim Trio:  
Breast MRS
Detection of choline 




• svs_se body WIP 
• spectral lipid suppression
• multi-array signal combination
• frequ. correction before accumulation






































































Magnetom Trio: 1H spectrum of liver
TE = 30 ms
TR = 2000ms
TA = 4:16 min
Voxel =  8 cm3
• free breathing SVS data acquisition
• frequency/phase lock for each acquisition



































Magnetom Avanto: 1H 
spectrum of liver
• universal body WIP svs_se
• free breathing
• frequ. / phase lock
• coil element combination
• TR / TE = 
650 / 30 ms
• Voxel size = 8 cc
• TA = 0:54 min
feasibility






































Single Voxel Spectroscopy in liver tumor
• free breathing  SVS data acquisition
• frequency/phase lock for each acquisition
• combining spectra of 8 coil elements
Magnetom Sonata:
Spectrum shows lipid signals
and increased Choline signal
TE =     135 ms
TR =     1500ms
TA =      0:48 min



































SVS in liver tumor
• free breathing  SVS data acquisition
• frequency/phase lock for each acquisition
• combining spectra of 8 coil elements
• Spectral lipid suprression
Magnetom Sonata:
Spectrum shows highly 
increased Choline signal
TE =     135 ms
TR =     1500ms
TA =      0:48 min









































































SVS in liver tumor
Comparison:







































































• MR spectroscopy of the prostate
• Outline of the trial
• Data
• PRISMA: Automatic post-processing 
• status report










































3D MRSI in 
prostate cancer
• Functional prostate tissue shows a 
marked citrate signal.
• In tumors the choline signal is 




































Objectives of the trial
• Primary objectives
– 3D 1H CSI detects prostate carcinoma
– 3D 1H CSI localizes prostate carcinoma
• Secondary objectives
– documenting inter-patient reproducibility of method
– documenting intra-patient reproducibility of method
– documenting variation due to patient age 
– documenting the robustness of the method
• Hypothesis
–Cho/Citrate or (Cho+Cr)/Citrate is significantly 






































































Patient’s Prostate Cancer MRI-
Histology
• The axial T2-weighted image 
is used for matching voxel 
locations to histopathological 
specimens. 
• One of the spectral maps, 
partially expanded, shows the 
quality of the MRSI data 
throughout the slice. 
• Deviations in the .   
(Cho + Cr) / Ci metabolite 
ratio map largely correspond 
to the tumor location 









































• Complex time domain fit
• Metabolite model 




• Automatic processing of 3D CSI data
mIns




































Quantification of Prostate 
Cancer Metabolites




































– Patients with prostate cancer who underwent a radical 
prostatectomy without prior treatment
• Anatomical imaging 
• 3D MRSI
• Histopathology
• Case report forms
– Young (<40 years) and age-matched (>55 years) healthy volunteers 
• Current work 
– Matching and classification of the data by experienced radiologists 
and physicists 











































































































































Body 3T Matrix (6 elements)
Body 3T Matrix (6 elements)
Surface coils consisting 
of many small elements
Spine 3T Matrix (6 elements)




































of 24 Ti m
elements
2D HASTE with PAT 2 
1.3x1.7x6 mm3, 20 slices, TA 
9 sec
50 cm










































































Pulse spacing in sequence defines 
spectral shape of citrate,
while choline and creatine as singlet signals 





















































Spectral shape of citrate at 3T
50 60 70 80 90 100 110 120 130 140 150 160 170 180 190
lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll








































65 75 85 95 105 115 125 135 145 155 165 175 185 195 205 
lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll
1 = 25 ms





























































































1 2 2 - 1
OVS


































1H-Prostate Spectroscopy at 3T
MAGNETOM Trio a Tim System
• 3D-CSI-SE scan for complete 
coverage of the prostate
• Measurement without an 
Endorectal Coil by using only 
Array Coils
• Optimized sequence timing for 3T
– TE 145 ms
– TR 750 ms
• 7x7x7 mm3 voxel 
• Spectral and spatial saturation 
pulses
• Scan time: 10 min



































• 3D Spin-Echo CSI
• sequence timing optimization 
TE = 145 ms; TR = 700 ms
• TA = 5:19 min !!
• scan matrix 14 x 14 x 8
• nominal voxel size 
7 x 7 x 7 mm3 = 0.33 cc
TIM Trio: Matrix Spectroscopy of 
the Prostate
• combined Spine and Body 
Matrix coil reception,
no usage of ER coil 
• truly non-invasive 
determination of the metabolic 







































































Single Voxel Spectroscopy in the Spinal Cord
svs_se  in the spinal cord, benefits from 
• Combined signal of body matrix
• ECG triggering 




































Single Voxel Spectroscopy in the Spinal Cord
svs_se  in the spinal cord, benefits from 
• Combined signal of body matrix
• ECG triggering 







































Lines are narrower 





































 g-Amino butyric acid: 
C4H9NO2
• methylene groups form 
A2M2X2 system
 g and b protons are 
weakly coupled, A2X2










































The challenge of GABA 
detection
• GABA conc. in the healthy 
occipital cortex: 1.0 mM



























































































1. g-Amino butyric 
acid: C4H9NO2
2. methylene groups 
form A2M2X2
system
3. g and b protons are 
weakly coupled, 
A2X2














































voxelsize = 27 cc, TA = 6’24 min



































MAGNETOM Trio: GABA Editing
 svs_se_edit 
by Mescher, Merkle, Kirsch, Garwood, Gruetter
In vivo spectral editing (MEGA, 2-shot)
 TE 68 ms
 voxelsize = 27 cc
 TA = 6’24min
 8-Channel Array Coil and offline signal combination 































































































































metabolite acq. water reference acq.








































Volumetric High Resolution 




































4 3 2 1 0
PPM
4 3 2 1 0
PPM
4 3 2 1 0
PPM
4 3 2 1 0
PPM
4 3 2 1 0
PPM
4 3 2 1 0
PPM
Volumetric High Resolution (64 x 64) 








































































SSFP-based Pulse Sequences I
• SSFP = steady state free precession
• fast sequence of RF-pulses, TR < T2, T1
• constant gradient net effect
 formation of 2 echo types
– fid-type of signal S1



































SSFP-based Pulse Sequences II
• 4 sequence types
• True-FISP = coherent combination 
of S1 and S2
– FAST = detection of only S1
– CE-FAST = detection of only S2
– FADE = separate detection 
of S1 and S2
• Usage in MRI
– suggested already in the 80s
– since end of the 90s: broad usage 
due to short TAmin and high efficiency 
• Usage for MRS to be explored
– is spectral resolution sufficient?
– can water suppression be integrated?
– what sequence type to be preferred?



































SSFP-based Pulse Sequences III
sequence efficiency
– W. Dreher et al., Magn. Reson. Med., 50: 453-460(2003)
• utilizing high sequence efficiency
• avoiding interferences between S1 and S2
– FAST = detection of only S1
– CE-FAST = detection of only S2
– FADE = separate detection of S1 and S2



































• 2D RF-pulses, 
selecting
–a spectral dimension
–a spatial dimension [1,2]
• composite pulse of 
– hard-pulses
– slice-selective pulses [3]
– timing 1-2-5.4--5.4-2-1
[1] Meyer et al, MRM 15(2), 1990
[2] Spielman et al, MRM 18(2), 1991



















































































• TR = 83 ms. acqu. window = 64ms, a = 40°
• voxelsize = 1 cc, matrix 32 x 32, FoV 200 
• TA = 1:29 min










































































PCr map of the control subject 




















































– Up to 8 RSat pulses 
– 1 repetition of each 
RSat pulse
– Pulse duration: 6400us
– (also available for 











































































volunteer PCr map 



































31P spectrum of the myocardium




































31P metabolite map of myocardial infarction
High correlation to  late enhancement
Late enhancement shows 
the infarct region in the 
anterior septal wall
The metabolite map shows low  PCr 
in the anterior septal region in 









































































NMR sensitivity of 13C vs. 1H
• identical B0, identical conc. of nuclei
sensitivity of 1H detection: 1 
sensitivity of 13C detection in vitro: ∞(g13C / g1H)
3 = 0.016




TA = 7 min.
13C, 3T, 



































Chemical dispersion 13C vs. 1H
• dispersion 13C = 20 x dispersion 1H
 shimming less important for 13C applications
 easier quantification
• 13C spectra show wealth of biochemical information
• 13C MRS can be used with labeled compounds



















































13C spectroscopy: the quest for 
sensitivity Coil design
surface coil vs.   1H volume & 13C quad.
13C




















































































13C spectroscopy: Sequential DEPT (DEPTUPS)


























































































– Prior knowledge based
– Complex time-domain fitting
– With qualification of results
• Report generation: 
– Fully automated mode
– No interaction for voxel/data selection or post-processing
– Based on predefined settings
• Report format: 
– Structured Report
– DICOM compatible




































• Complex fit in time-domain
• Using model signals, based on analytical or 
simulated (GAMMA) models
• Gaussian, Lorentzian and Voigt lineshapes








Fit of short TE in vivo data (SVS, SE, TE 30 ms)
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Metabolite report includes
–patient info
–localization info
–metabolic info
–diagnostic info
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